Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
ESSA Pharma Inc | EPIX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
9.10 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 2.56 - 11.67 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 9.10 | USD |
ESSA Pharma Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
402.57M | 44.24M | - | 0 | -26.58M | -0.60 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
ESSA Pharma News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EPIX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 9.02 | 9.32 | 8.52 | 8.99 | 42,908 | 0.08 | 0.89% |
1 Month | 9.14 | 9.92 | 7.17 | 8.72 | 89,697 | -0.04 | -0.44% |
3 Months | 6.82 | 11.67 | 5.70 | 9.06 | 165,981 | 2.28 | 33.43% |
6 Months | 2.76 | 11.67 | 2.63 | 6.43 | 174,345 | 6.34 | 229.71% |
1 Year | 2.95 | 11.67 | 2.56 | 5.70 | 110,813 | 6.15 | 208.47% |
3 Years | 30.51 | 36.00 | 1.40 | 6.82 | 496,137 | -21.41 | -70.17% |
5 Years | 3.55 | 36.00 | 1.40 | 7.61 | 333,435 | 5.55 | 156.34% |
ESSA Pharma Description
ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. |